Please log in to access this page.

Mixtard human 70/30 and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Mixtard human 70/30 (insulin recombinant purified human; insulin susp isophane semisynthetic purified human), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Cefuroxime Sodium, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Fainting when taking Mixtard human 70/30. It is created by eHealthMe based on reports of 1,117 people who have side effects when taking Mixtard human 70/30 from the FDA, and is updated regularly.

What is Mixtard human 70/30?

Mixtard human 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is often used in type 1 diabetes. eHealthMe is studying from 1,131 Mixtard human 70/30 users. Check the latest studies of Mixtard human 70/30.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,446 drugs and 3,548 conditions by eHealthMe. Check the latest studies of Fainting.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

1,117 people reported to have side effects when taking Mixtard human 70/30.
Among them, 13 people (1.16%) have Fainting.

Could Mixtard human 70/30 cause Fainting?

Among these 13 people:

How long have people been on Mixtard human 70/30 when they have Fainting? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 40 %
  • 6 - 12 months: 60 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Fainting when taking Mixtard human 70/30? *

  • female: 38.46 %
  • male: 61.54 %

What is the age of people who have Fainting when taking Mixtard human 70/30? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 23.08 %
  • 60+: 76.92 %

What are other drugs people take besides Mixtard human 70/30? *

  1. Doxazosin Mesylate: 3 people, 23.08%
  2. Torsemide: 3 people, 23.08%
  3. Saxagliptin: 3 people, 23.08%
  4. Prinivil: 3 people, 23.08%
  5. Aspirin: 3 people, 23.08%
  6. Fosinopril Sodium: 3 people, 23.08%
  7. Metoprolol Tartrate: 3 people, 23.08%
  8. Bisoprolol Fumarate: 3 people, 23.08%
  9. Cefuroxime Sodium: 3 people, 23.08%
  10. Allopurinol: 2 people, 15.38%

What are other side effects people have besides Fainting? *

  1. Loss Of Consciousness: 3 people, 23.08%
  2. Abdominal Pain Upper: 3 people, 23.08%
  3. Blood Urea Increased: 3 people, 23.08%
  4. Renal Disorder (kidney disease): 3 people, 23.08%
  5. Injection Site Swelling: 3 people, 23.08%
  6. Blood Creatinine Increased: 3 people, 23.08%
  7. Pneumonia: 3 people, 23.08%
  8. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 3 people, 23.08%
  9. Nausea And Vomiting: 2 people, 15.38%
  10. Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 2 people, 15.38%

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 5 people, 38.46%
  2. High Blood Pressure: 3 people, 23.08%
  3. Diabetes: 2 people, 15.38%
  4. Hepatic Neoplasm Malignant Non-Resectable (liver cancer non-resectable): 1 person, 7.69%
  5. Heart Attack: 1 person, 7.69%
  6. Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mixtard human 70/30 and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mixtard human 70/30:

Fainting treatments and more:

How severe was Fainting and when was it recovered:

Expand to all the drugs that have ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mixtard human 70/30:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Browse all the conditions that are associated with Fainting:


How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Mixtard human 70/30) and Mixtard human 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: